Endocrinology Flashcards
Carcinoid syndrome Management (localised)
NO distant mets
Surgical resection + peri-op octreotide infusion (prevents crisis)
Carcinoid syndrome Management (metastatic)
Resection + octreotide infusion if suitable
NOT suitable;
Octreotide 100-600mg/day SC then 20-30mg IM once dose established. Alternative: IFN a
Second line: hepatic transarterial embolisation
Third: radionucleotide therapy with labelled SSAs
Complications of carcinoid syndrome
Crisis: flushing, severe BP drop, bronchospasm. Mx = octreotide
Carcinoid heart dx: tricuspid and pulonary regurg -> RHF (oedema, SOB) Mx: Na/H2O restriction +/- loop diuretic +/- digoxin
Prognosis of carcinoid syndrome
95% 5yr survival
80% with liver mets
Poorer with cardiac disease
Graves Disease Management Thyroid storm
- Propylthiouracil 500-1000mg PO loading dose, then 250mg PO every 4hrs OR carbimazole
- AND hydrocortisone 300mg IV loading dose then 100mg TDS
- AND propranolol 60-80mg PO immedaite release evry 4-6hrs
- AND Iodine/K iodide (Lugol solution) 5 drops (250mg) PO Every 6hrs
- Potential adjuncts: colestyramine (bile acid sequester to reduce enterhepative circulation of thryoid hormones Lithium (reduces hormone secretion)
Graves management subclincal
Treat TSH <0.1mlU/L in >65yo and post-menopausal women (not on oestrogens or bisphosphonates), OR patients with Cardiac RF/disease, osteoporosis or symptoms of hyperthyroidism
Graves anti-thyroid drugs management symptomatic (not pregnant/lactating)
- Medical: Carbimazole 20-40mg/day PO adjust dose to response (usual maintenance 5-15mg/day)
a. Second option: propylthiouracil 150-400mg/day
b. Alternative: Block and replace (high dose anti-thyroid plus levothroxine)
Adjunct: propranolol for symptom relief
Graves disease management options categories
- medical
- radioiodine
- sugery
Graves management medical (not antithyroid)
Radioiodine + PO pred 30-40mg OD PO 4wks then taper dose
Graves management surgery
Thyroid surgery
(sub)total resection preferred to eliminate risk of future hyperthyroid
Graves disease monitoring
MONITOR TFTs at 6 weeks, 3 months, 6 months, 12 months
Graves disease management pregnant/lactating
- Propylthiouracil 50-300mg/day over three doses +/- propranolol
Surgery only in second trimester in patients with anti-thyroid allergies
Graves disease Complications
Thyroid storm
Hypothyroidism: dose adjustment +/- levothyroxine
Arrhythmias (AF): beta blockade and anti-thyroid
Orbitopathy: drops, sun glasses consider short course low dose steroid
Dermatopathy: topical steroids
Radio + surgery: permanent hypothyroidism
Surgery: recurrent laryngeal n. injury
Graves prognosis
Generally good especially with good monitoring
Not ‘curable’ options are to supress gland with meds or definitive management will mean life long replacement
Thyroid storm carries 20-30% mortality (likely factor of other comorbidities)